Medicinal Chemistry - Fusion of Traditional and Western Medicine, First Edition


by

Robert E. Smith

DOI: 10.2174/97816080514961130101
eISBN: 978-1-60805-149-6, 2013
ISBN: 978-1-60805-154-0



Indexed in: Scopus

Medicinal Chemistry - Fusion of Traditional and Western Medicine is a textbook ...[view complete introduction]

How New Drugs are Developed: Basic Science, Lead Compound and Proof of Principle

- Pp. 87-116 (30)

Robert E. Smith

Abstract

Drugs are developed in distinct phases. Usually, the drug discovery and development process can be divided into these stages: select a disease, identify a target, find a lead compound, quantify drug-target interactions, determine solubility, pharmacokinetics and toxicity, improve the lead compound, find the best way to deliver the drug to the patient, manufacture the drug, apply to the FDA to do investigational studies, do the clinical studies, apply to the FDA for drug approval, and do post-registration studies. The solubility, pharmacokinetics and toxicity are determined in GLP studies. Similar compounds are tested in the lab and by computer modeling, so structure-activity relationships (SARs) can be developed. Eventually, a new chemical entity (NCE) or investigational new drug (IND) is selected for further evaluation. The optimum method for drug delivery is selected. A manufacturing process is developed and documented according to cGMP. Potential targets include membrane bound receptors (such as GPCRs, tyrosine kinases and intracellular nuclear receptors). Agonists bind to receptors and mimic the action of the endogenous ligand. Antagonists bind to receptors and block the binding and subsequent action of the endogenous ligand. Enzymes, DNA, protein transporters, ion channels and pumps are other potential targets.

Purchase Chapter  Book Details

Advertisement


Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science